KalVista Pharmaceuticals, Inc. reports

Company location: Framingham, MA
Fiscal year end: 31 December

KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 301-325 of 882 matching filings.

Per page

25

Current page

13

4

FORM 4 SUBMISSION

Filing date: 21 Nov 2023
Reporting date: 17 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Nov 2023
Reporting date: 17 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Nov 2023
Reporting date: 17 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Nov 2023
Reporting date: 30 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36830

8-K

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 13 Sep 2023
Reporting date: 11 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36830

144 filing

Filing date: 11 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36830

8-K

Filing date: 07 Sep 2023
Reporting date: 07 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36830

10-Q

Filing date: 07 Sep 2023
Reporting date: 31 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

ARS File 001-36830

ARS

Filing date: 14 Aug 2023
Reporting date: 30 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-36830

DEFA14A

Filing date: 14 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36830

DEF 14A

Filing date: 14 Aug 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-36830

PRE 14A

Filing date: 04 Aug 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36830

8-K

Filing date: 10 Jul 2023
Reporting date: 07 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36830

10-K

Filing date: 10 Jul 2023
Reporting date: 30 Apr 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .